{
  "question": "Calcitonin is not given in which disease -",
  "is_multi_choice": true,
  "correct_answer": "opb",
  "options": {
    "opa": "Paget's disease",
    "opb": "Thyrotoxicosis",
    "opc": "Hyperparathyroidism",
    "opd": "Hypervitaminosis D"
  },
  "topic_name": "Pharmacology",
  "context": null,
  "initial_causal_graph": {
    "entities_pairs": {
      "start": [],
      "end": []
    },
    "nodes": [
      [
        "Osteitis Deformans",
        "Disease"
      ],
      [
        "Hyperparathyroidism",
        "Disease"
      ],
      [
        "Thyrotoxicosis",
        "Disease"
      ],
      [
        "Disease",
        "Bone Diseases",
        "Osteitis Deformans"
      ],
      [
        "Disease",
        "Cone-Rod Dystrophy 2",
        "Osteitis Deformans"
      ],
      [
        "Disease",
        "Bone lesion",
        "Osteitis Deformans"
      ],
      [
        "Disease",
        "Hyperparathyroidism"
      ],
      [
        "Disease",
        "Thyrotoxicosis"
      ],
      [
        "Calcitonin",
        "Osteitis Deformans"
      ],
      [
        "Calcitonin",
        "Hyperparathyroidism"
      ],
      [
        "Calcitonin",
        "Thyrotoxicosis"
      ]
    ],
    "relationships": [
      [
        "CAUSES"
      ],
      [
        "CAUSES"
      ],
      [
        "CAUSES"
      ],
      [
        "CAUSES",
        "CAUSES"
      ],
      [
        "CAUSES",
        "CAUSES"
      ],
      [
        "CAUSES",
        "CAUSES"
      ],
      [
        "CAUSES"
      ],
      [
        "CAUSES"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ]
    ],
    "paths": [
      "(Osteitis Deformans)-CAUSES->(Disease)",
      "(Hyperparathyroidism)-CAUSES->(Disease)",
      "(Thyrotoxicosis)-CAUSES->(Disease)",
      "(Disease)-CAUSES->(Bone Diseases)-CAUSES->(Osteitis Deformans)",
      "(Disease)-CAUSES->(Cone-Rod Dystrophy 2)-CAUSES->(Osteitis Deformans)",
      "(Disease)-CAUSES->(Bone lesion)-CAUSES->(Osteitis Deformans)",
      "(Disease)-CAUSES->(Hyperparathyroidism)",
      "(Disease)-CAUSES->(Thyrotoxicosis)",
      "(Calcitonin)-TREATS->(Osteitis Deformans)",
      "(Calcitonin)-TREATS->(Hyperparathyroidism)",
      "(Calcitonin)-TREATS->(Thyrotoxicosis)"
    ]
  },
  "causal_graph": {
    "entities_pairs": {
      "start": [],
      "end": []
    },
    "nodes": [],
    "relationships": [],
    "paths": []
  },
  "knowledge_graph": {
    "entities_pairs": {
      "start": [],
      "end": []
    },
    "nodes": [
      [
        "Calcitonin",
        "Pharmaceutical Preparations",
        "Bone Density"
      ],
      [
        "Calcitonin",
        "Epithelium",
        "Calcium measurement"
      ],
      [
        "Hypercalcemia",
        "Complication",
        "Calcitonin"
      ],
      [
        "Hypercalcemia",
        "Complication",
        "Calcitonin"
      ],
      [
        "Hypercalcemia",
        "Complication",
        "Calcitonin"
      ]
    ],
    "relationships": [
      [
        "ISA",
        "CAUSES"
      ],
      [
        "PART_OF",
        "LOCATION_OF"
      ],
      [
        "MANIFESTATION_OF",
        "ASSOCIATED_WITH"
      ],
      [
        "CAUSES",
        "ASSOCIATED_WITH"
      ],
      [
        "COMPLICATES",
        "ASSOCIATED_WITH"
      ]
    ],
    "paths": [
      "(Calcitonin)-ISA->(Pharmaceutical Preparations)-CAUSES->(Bone Density)",
      "(Calcitonin)-PART_OF->(Epithelium)-LOCATION_OF->(Calcium measurement)",
      "(Hypercalcemia)-MANIFESTATION_OF->(Complication)-ASSOCIATED_WITH->(Calcitonin)",
      "(Hypercalcemia)-CAUSES->(Complication)-ASSOCIATED_WITH->(Calcitonin)",
      "(Hypercalcemia)-COMPLICATES->(Complication)-ASSOCIATED_WITH->(Calcitonin)"
    ]
  },
  "enhanced_graph": {
    "entities_pairs": {
      "start": [],
      "end": []
    },
    "nodes": [],
    "relationships": [],
    "paths": [
      "(Calcitonin)-ISA->(Pharmaceutical Preparations)-CAUSES->(Bone Density)",
      "(Calcitonin)-PART_OF->(Epithelium)-LOCATION_OF->(Calcium measurement)",
      "(Hypercalcemia)-MANIFESTATION_OF->(Complication)-ASSOCIATED_WITH->(Calcitonin)",
      "(Hypercalcemia)-CAUSES->(Complication)-ASSOCIATED_WITH->(Calcitonin)",
      "(Hypercalcemia)-COMPLICATES->(Complication)-ASSOCIATED_WITH->(Calcitonin)"
    ]
  },
  "reasoning_chain": [
    "Calcitonin use in Paget's disease -> promotes bone density -> potential benefit in treatment -> 80%",
    "Calcitonin use in thyrotoxicosis -> may inhibit bone resorption -> unclear impact on thyroid function -> 70%",
    "Calcitonin use in hyperparathyroidism -> counteracts elevated calcium levels -> potential therapeutic role -> 75%",
    "Calcitonin use in hypervitaminosis D -> ineffective against vitamin D toxicity -> no role in calcium regulation -> 85%",
    "Hypervitaminosis D -> leads to hypercalcemia -> calcitonin not indicated -> 90%"
  ],
  "enhanced_information": "Calcitonin is not indicated in hypervitaminosis D. The reasoning chain indicates that calcitonin is ineffective against vitamin D toxicity and does not play a role in calcium regulation, which is critical since hypervitaminosis D leads to hypercalcemia. The evidence supporting this conclusion is strong, with a confidence level of 90%. In contrast, calcitonin has potential benefits in Paget's disease (promoting bone density), thyrotoxicosis (inhibiting bone resorption), and hyperparathyroidism (counteracting elevated calcium levels), with confidence levels of 80%, 70%, and 75% respectively. Therefore, hypervitaminosis D is the most likely condition where calcitonin is not used.",
  "analysis": "Calcitonin is a hormone that helps regulate calcium levels in the body and is primarily used in conditions associated with increased bone resorption and elevated calcium levels. In Paget's disease, calcitonin can help reduce bone turnover and promote bone density. In thyrotoxicosis, it can inhibit bone resorption, and in hyperparathyroidism, it can counteract elevated calcium levels. However, in hypervitaminosis D, the condition is characterized by excessive vitamin D leading to hypercalcemia, and calcitonin is ineffective in this scenario. Therefore, based on standard medical knowledge and the enhanced information provided, calcitonin is not indicated in hypervitaminosis D, making it the correct answer.",
  "answer": "opd",
  "confidence": 90.0,
  "chain_coverage": {
    "success_counts": [
      1,
      0,
      1,
      0,
      1
    ],
    "coverage_rates": [
      33.33333333333333,
      0.0,
      33.33333333333333,
      0.0,
      33.33333333333333
    ],
    "total_successes": 3
  }
}